Cargando…
Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore
INTRODUCTION: Following the March 2020 federal declaration of a COVID-19 public health emergency, in line with recommendations for social distancing and decreased congregation, federal agencies issued sweeping regulation changes to facilitate access to medications for opioid use disorder (MOUD) trea...
Autores principales: | Abidogun, Tolulope M., Cole, Thomas O., Massey, Ebonie, Kleinman, Mary, Greenblatt, Aaron D., Seitz-Brown, C.J., Magidson, Jessica F., Belcher, Annabelle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822549/ https://www.ncbi.nlm.nih.gov/pubmed/36880915 http://dx.doi.org/10.1016/j.josat.2022.208946 |
Ejemplares similares
-
“Sometimes you have to take the person and show them how”: adapting behavioral activation for peer recovery specialist-delivery to improve methadone treatment retention
por: Kleinman, Mary B., et al.
Publicado: (2023) -
Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial
por: Belcher, Annabelle M., et al.
Publicado: (2023) -
Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19
por: Greenblatt, Aaron D., et al.
Publicado: (2020) -
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
por: Belcher, Annabelle M, et al.
Publicado: (2019) -
Race-based differences in drug use prior to onset of opioid use disorder
por: Deutsch-Link, Sasha, et al.
Publicado: (2023)